4-CHLORO-1-(2-FLUORO-BENZYL)-1H-PYRAZOL-3-YLAMINE
- $445 - $798
- Product name: 4-CHLORO-1-(2-FLUORO-BENZYL)-1H-PYRAZOL-3-YLAMINE
- CAS: 1001757-51-2
- MF: C10H9ClFN3
- MW: 225.65
- EINECS:
- MDL Number:MFCD02254015
- Synonyms:ART-CHEM-BB B001316;AKOS B001316;4-CHLORO-1-(2-FLUOROBENZYL)-1H-PYRAZOL-3-AMINE;4-CHLORO-1-(2-FLUORO-BENZYL)-1H-PYRAZOL-3-YLAMINE;1H-Pyrazol-3-amine, 4-chloro-1-[(2-fluorophenyl)methyl]-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Apolloscientific
- Crysdot
- SynQuest Laboratories
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0257171
- Product description4-CHLORO-1-(2-FLUORO-BENZYL)-1H-PYRAZOL-3-YLAMINE 95.00%
- Packaging5MG
- Price$497.83
- Updated2021-12-16
- Buy
- ManufacturerApolloscientific
- Product numberPC410297
- Product description4-Chloro-1-(2-fluorobenzyl)-1H-pyrazol-3-amine
- Packaging1g
- Price$445
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11370315
- Product description4-Chloro-1-(2-fluorobenzyl)-1H-pyrazol-3-amine 95+%
- Packaging1g
- Price$798
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3H30-7-2D
- Product description4-Chloro-1-(2-fluorobenzyl)-1H-pyrazol-3-amine
- Packaging1g
- Price$712
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0257171 | 4-CHLORO-1-(2-FLUORO-BENZYL)-1H-PYRAZOL-3-YLAMINE 95.00% | 5MG | $497.83 | 2021-12-16 | Buy |
Apolloscientific | PC410297 | 4-Chloro-1-(2-fluorobenzyl)-1H-pyrazol-3-amine | 1g | $445 | 2021-12-16 | Buy |
Crysdot | CD11370315 | 4-Chloro-1-(2-fluorobenzyl)-1H-pyrazol-3-amine 95+% | 1g | $798 | 2021-12-16 | Buy |
SynQuest Laboratories | 3H30-7-2D | 4-Chloro-1-(2-fluorobenzyl)-1H-pyrazol-3-amine | 1g | $712 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|